Payers and targeted therapy in oncology

I was quoted in a recent article in Pharmaceutical Technology titled “Targeted therapies to join chemo as oncology treatment backbone“. An excerpt is below: Though payers could theoretically prioritise chemotherapy over the use of targeted treatments due to their lower price, Jason Shafrin, senior managing director of FTI’s Center for Healthcare Economics and Policy, notes…

Read More

Keys to Provider Patient Communications Amidst President Trump’s Massive Policy Shifts 

Exactly what the administration is ultimately able to accomplish will be anyone’s guess, but here are some key policy and market shifts healthcare leaders and their PR teams should watch closely and be prepared to communicate around.    The post Keys to Provider Patient Communications Amidst President Trump’s Massive Policy Shifts  appeared first on MedCity News.

Read More

Readers Scrutinize Federal Cuts and Medical Debt

Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Trump Team’s Rhetoric Doesn’t Match Actions The recent KFF Health News article “Beyond Ivy League, RFK Jr.’s NIH Slashed Science Funding Across States That Backed Trump” (April 17) struck a nerve….

Read More

HHS’s Independence: If Not Now, When?

By DAVID INTROCASO After having worked in DC for sixteen years, in 2013 I created The Healthcare Policy Podcast.  The title was in part intended to be sarcastic because healthcare policymaking in DC is very narrowly drawn.  Consequently, healthcare delivery is excessively commodified, reductionistic and financialized or in sum anachronistic and ironically lacking purchase.  If the…

Read More